GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atrys Health SA (FRA:A2T) » Definitions » Total Payout Ratio

Atrys Health (FRA:A2T) Total Payout Ratio : 0.02 (As of Dec. 15, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Atrys Health Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Atrys Health's current Total Payout Ratio is 0.02.


Atrys Health Total Payout Ratio Historical Data

The historical data trend for Atrys Health's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atrys Health Total Payout Ratio Chart

Atrys Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Payout Ratio
Get a 7-Day Free Trial -24.60 6.38 -0.01 3.08 0.01

Atrys Health Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.54 0.46 -0.01 0.04 -

Competitive Comparison of Atrys Health's Total Payout Ratio

For the Biotechnology subindustry, Atrys Health's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atrys Health's Total Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Atrys Health's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Atrys Health's Total Payout Ratio falls into.



Atrys Health Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Atrys Health's Total Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0.287 + 0 + 0) / -33.696
=0.01

Atrys Health's Total Payout Ratio for the quarter that ended in Jun. 2024 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0.013 + 0 + 0) / -17.702
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Atrys Health Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Atrys Health's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Atrys Health Business Description

Traded in Other Exchanges
Address
Calle Provenca, 392 planta baja, Barcelona, ESP, 08025
Atrys Health SA is a Spain based biomedical company which focuses on developing tools for the diagnosis and treatment of cancer and precancerous conditions. It offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics. The company uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology.

Atrys Health Headlines

No Headlines